CANADABIS CAPITAL WITH SUB STIGMA GROW ANNOUNCES RECORD $7.8M REVENUE FOR FISCAL Q1 2023 UP 22% OVER Q4 2022, HIGHLIGHTED BY SIGNIFICANT GROWTH IN NET REVENUE, GROSS PROFIT AND EARNINGS

/CNW/ - CanadaBis Capital Inc. with its wholly owned sub Stigma Grow (the "Company" or "CanadaBis") (TSXV: CANB) a premium vertically integrated Canadian...

Related Keywords

Goldstream ,British Columbia ,Canada ,United States ,America ,Canadian ,Travis Mcintyre ,Stigma Pharmaceuticals Inc ,Spectrum Labs Ltd ,Company Financial ,Alberta Ltd ,Canadabis Capital Inc ,Goldstream Cannabis Inc ,Stigma Grow The Company Or Canadabis ,Bis Capital ,Stigma Grow ,Financial Statements ,Net Income ,Net Revenue ,Dab Bod Brand ,High Priestess ,Unit Sales ,Strong Brand Demand ,Meet Customer Demands ,Licensed Producer ,Spectrum Labs ,